Guardant Health has a history of beating EPS estimates, which has often led to a share price increase. However, the stock has been down 27.68% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders. The upcoming earnings report could potentially influence the stock's performance, depending on whether the company beats the EPS estimate and provides positive guidance for the next quarter.